NCT06981052

Brief Summary

Lumen apposing metal stents are now being used to help patients who suffer from cholecystitis (infection of the gallbladder), especially in cases where patients are not candidates for surgery. Lumen apposing metal stents are effective for draining the gallbladder, however, placement is technically challenging. Scientists have developed an artificial intelligence to aid doctors in the deployment of these stents into the gallbladder. The aim of this study is test the performance of an artificial intelligence in providing physicians accurate information for gallbladder drainage.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 24, 2025

Completed
18 days until next milestone

Study Start

First participant enrolled

May 12, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 20, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

April 24, 2025

Last Update Submit

March 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Accuracy of the EUS AI system in providing a recommendation (i.e. whether it is safe or not to drain the gallbladder)

    An expert endoscopist will perform the endoscopic ultrasound procedure. When the gallbladder comes into view the expert will comment as to whether they believe that the gallbladder is safe to drain. The expert will be blinded to the AI computers interpretation of the view of the gallbladder. A second observer will record what the AI recommended at the time of the blinded expert. The expert will be considered the "gold standard" and the outcome will be accuracy of the AI in mimicking the experts recommendations.

    Day 1

Study Arms (1)

Patients with gallbladders undergoing AI evaluation for stent deployment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing endoscopic ultrasound who have a gallbladder present

You may qualify if:

  • Age ≥ 18 years old
  • Anticipation that patient may undergo endoscopic ultrasound
  • Gallbladder present

You may not qualify if:

  • Cholecystectomy
  • No indication for endoscopic ultrasound

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UMass Chan Medical School/Umass Memorial Health Care

Worcester, Massachusetts, 01655, United States

Location

MeSH Terms

Conditions

Cholecystitis

Condition Hierarchy (Ancestors)

Gallbladder DiseasesBiliary Tract DiseasesDigestive System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Clinical Professor of Medicine

Study Record Dates

First Submitted

April 24, 2025

First Posted

May 20, 2025

Study Start

May 12, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

March 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Other researchers can reach out to UMass Chan to obtain deidentified data on a case-by-case basis.

Shared Documents
STUDY PROTOCOL, SAP

Locations